title: New treatment strategy for Smith-Lemli-Opitz syndrome.
authors.forename: P
authors.initials: P
authors.lastname: Jira
authors.forename: R
authors.initials: R
authors.lastname: Wevers
authors.forename: J
authors.initials: J
authors.lastname: de Jong
authors.forename: E
authors.initials: E
authors.lastname: Rubio-Gozalbo
authors.forename: J
authors.initials: J
authors.lastname: Smeitink
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D003684:Dehydrocholesterols / Q000097:blood; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007223:Infant; D008148:Lovastatin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019821:Simvastatin; D019082:Smith-Lemli-Opitz Syndrome / Q000188:drug therapy / Q000628:therapy*
chemical_list: D000924:Anticholesteremic Agents; D003684:Dehydrocholesterols; D004791:Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008148:Lovastatin; D019821:Simvastatin; C016705:7-dehydrocholesterol